Structure and function relationships in IgA

Mucosal Immunology

Volumn 4, Issue 6, 2011, Pages 590-597

  Woof, J M ^a   Russell, M W ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FCALPHA MU RECEPTOR; FCALPHA RECEPTOR I; GLYCAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN HEAVY CHAIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROTEIN CBPA; PROTEINASE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; BINDING SITE; COMPLEMENT ACTIVATION; HOST RANGE; HUMAN; HYDROPHILICITY; IMMUNOGLOBULIN STRUCTURE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STREPTOCOCCUS PNEUMONIA; STRUCTURE ACTIVITY RELATION;

EID: 80054902426     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2011.39     Document Type: Review

References (85)

1. Burnett R. C. Hanly W. C. Zhai S. K. & Knight K. L. The IgA heavy chain gene family in rabbit: cloning and sequence analysis of 13 Cα genes. EMBO J. 8 4041-4047 ( 1989 (Pubitemid 20066845)
2. Kawamura S. Saitou N. & Ueda S. Concerted evolution of the primate immunoglobulinα -gene through gene conversion. J. Biol. Chem. 267 7359-7367 ( 1992
3. Herr A. B. Ballister E. R. & Bjorkman P. J. Insights into IgA-mediated immune responses from the crystal structures of human FCα RI and its complex with IgA1-Fc. Nature. 423 614-620 ( 2003 (Pubitemid 36713216)
4. Ramsland P. A. et al. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc. Natl Acad. Sci. USA 104 15051-15056 ( 2007 (Pubitemid 47619591)
5. Mattu T. S. et al. The glycosylation and structure of human serum IgA1Fab and Fc regions and the role of N-glycosylation on FCα receptor interactions. J. Biol. Chem. 273 2260-2272 ( 1998 (Pubitemid 28069279)
6. Royle L. et al. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J. Biol. Chem. 278 20140-20153 ( 2003 (Pubitemid 36799209)
7. Tarelli E. Smith A. C. Hendry B. M. Challacombe S. J. & Pouria S. Human serum IgA1 is substituted with up to six O -glycans as shown by matrix assisted laser desorption ionisation time-of-fl ight mass spectrometry. Carbohydrate Res. 339 2329-2335 ( 2004 (Pubitemid 39165126)
8. Narimatsu Y. et al. Effect of glycosylation on the cis/trans isomerization of prolines in IgA1-hinge peptide. J. Am. Chem. Soc. 132 5548-5549 ( 2010
9. Field M. C. Amatayakul-Chantler S. Rademacher T. W. Rudd P. M. & Dwek R. A. Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem. J. 299 261-275 ( 1994 (Pubitemid 24106318)
10. Krugmann S. Pleass R. J. Atkin J. D. & Woof J. M. Structural requirements for assembly of dimeric IgA probed by site-directed mutagenesis of J chain and a cysteine residue of theα chain CH2 domain. J. Immunol. 159 244-249 ( 1997 (Pubitemid 127493706)
11. Atkin J. D. Pleass R. J. Owens R. J. & Woof J. M. Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly. J. Immunol. 157 156-159 ( 1996 (Pubitemid 26190542)
12. Yoo E. M. et al. Structural requirements for polymeric immunoglobulin assembly and association with J chain. J. Biol. Chem. 274 33771-33777 ( 1999 (Pubitemid 129511694)
13. Braathen R. Sorensen V. Brandtzaeg P. Sandlie I. & Johansen F. E. The carboxyl-terminal domains of IgA and IgM direct isotype-specifi c polymerization and interaction with the polymeric immunoglobulin receptor. J. Biol. Chem. 277 42755-42762 ( 2002 (Pubitemid 35285648)
14. Zikan J. et al. Secondary structure of the immunoglobulin J chain. Proc. Natl Acad. Sci. USA 82 5905-5909 ( 1985
15. Frutiger S. Hughes G. J. Paquet N. Luthy R. & Jaton J. C. Disulfi de bond assignment in human J chain and its covalent pairing with immunoglobulin M. Biochemistry. 31 12643-12647 ( 1992 (Pubitemid 23016531)
16. Johansen F. E. Braathen R. & Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J. Immunol. 167 5185-5192 ( 2001 (Pubitemid 33009755)
17. Bonner A. Perrier C. Corthesy B. & Perkins S. J. Solution structure of human secretory component and implications for biological function. J. Biol. Chem. 282 16969-16980 ( 2007 (Pubitemid 47093200)
18. Norderhaug I. N. Johansen F. E. Krajci P. & Brandtzaeg P. Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric and pentameric IgM interaction. Eur. J. Immunol. 29 3401-3409 ( 1999 (Pubitemid 29484231)
19. Bakos M. A. Kurosky A. Cwerwinski E. W. & Goldblum R. M. A conserved binding site on the receptor for polymeric Ig is homologous to CDR1 of Ig V kappa domains. J. Immunol. 151 1346-1352 ( 1993 (Pubitemid 23219271)
20. Coyne R. S. Siebrecht M. Peitsch M. C. & Casanova J. E. Mutational analysis of polymeric immunoglobulin receptor/ligand interactions. Evidence for the involvement of multiple complementarity determiningregion (CDR)-like loops in receptor domain I. J. Biol. Chem. 26931620-31625 ( 1994
21. Hamburger A. E. West A. P. Jr. & Bjorkman P. J. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure (Camb) 12 1925-1935 ( 2004 (Pubitemid 39469390)
22. Underdown B. J. DeRose J. & Plaut A. Disulfi de bonding of secretory component to a single monomer subunit in human secretory IgA. J. Immunol. 118 1816-1821 ( 1977 (Pubitemid 8097385)
23. Fallgren-Gebauer E. et al. The covalent linkage of the secretory component to IgA. Adv. Exp. Med. Biol. 371A 625-628 ( 1995
24. Bonner A. Almogren A. Furtado P. B. Kerr M. A. & Perkins S. J. Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity. Mucosal Immunol. 2 74-84 ( 2009
25. Bonner A. Almogren A. Furtado P. B. Kerr M. A. & Perkins S. J. The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses. J. Biol. Chem. 284 5077-5087 ( 2009
26. Otten M. A. & van Egmond M. The Fc receptor for IgA (FCα RICD89). Immunol. Lett. 92 23-31 ( 2004
27. Carayannopoulos L. Hexham J. M. & Capra J. D. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα 2 and Cα 3 in human IgA1. J. Exp. Med 183 1579-1586 ( 1996
28. Pleass R. J. Dunlop J. I. Anderson C. M. & Woof J. M. Identifi cation of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human FCα receptor (FCα R) CD89. J. Biol. Chem. 274 23508-23514 ( 1999
29. Woof J. M. & Burton D. R. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. 4 89-99 ( 2004 (Pubitemid 38209203)
30. Abi-Rached L. Dorighi K. Norman P. J. Yawata M. & Parham P. Episodes of natural selection shaped the interactions of IgA-Fc with FCα RI and bacterial decoy proteins. J. Immunol. 178 7943-7954 ( 2007 (Pubitemid 46898066)
31. Hexham J. M. et al. A human immunoglobulin (Ig)A Cα 3 domain motif directs polymeric Ig receptor-mediated secretion. J. Exp. Med. 189 747-752 ( 1999
32. White K. D. & Capra J. D. Targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides. J. Exp. Med. 196 551-555 ( 2002
33. Lewis M. J. Pleass R. J. Batten M. R. Atkin J. D. & Woof J. M. Structural requirements for the interaction of human IgA with the human polymeric Ig receptor. J. Immunol. 175 6694-6701 ( 2005 (Pubitemid 41598913)
34. van Egmond M. et al. FCα RI-positive liver Kuppfer cells: reappraisal of the function of immunoglobulin A in immunity. Nat. Med. 6 680-685 ( 2000 (Pubitemid 30398792)
35. van Spriel A. B. Leusen J. H. ViléH. & van de Winkel J. G. Mac-1 (CD11b/CD18) as accessory molecule for FCα R (CD89) binding of IgA. J. Immunol. 169 3831-3836 ( 2002
36. Stewart W. W. & Kerr M. A. The specifi city of the human neutrophil IgA receptor (FCα R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Immunology. 71 328-334 ( 1990
37. Shibuya A. & Honda S. I. Molecular and functional characteristics of the FCα /μ Ra novel Fc receptor for IgM and IgA. Springer Semin. Immun. 28 377-382 ( 2006 (Pubitemid 44900576)
38. Kikuno K. et al. Unusual biochemical features and follicular dendritic cell expression of human FCα /μ receptor. Eur. J. Immunol. 37 3540-3550 ( 2007
39. Wang R. Fu Y. Zhao Q. Pan L. & Zhang W. Human FCα /μ R and pIgR distribute differently in intestinal tissues. Biochem. Biophys. Res. Commun. 381 148-152 ( 2009
40. Ghumra A. et al. Structural requirements for the interaction of human IgM and IgA with the human FCα /μ receptor. Eur. J. Immunol. 39 1147-1156 ( 2009
41. Yoo E. M. Trinh K. R. Lim H. Wims L. A. & Morrison S. L. Characterization of IgA and IgM binding and internalization by surfaceexpressed human FCα /μ receptor. Mol. Immunol. 48 1818-1826 ( 2011
42. Wold A. et al. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fi mbrial lectin. Infect. Immun. 58 3073-3077 ( 1990 (Pubitemid 20267705)
43. Ruhl S. Sandberg A. L. Cole M. F. & Cisar J. O. Recognition of immunoglobulin A1 by oral actinomyces and streptococcal lectins. Infect. Immun. 64 5421-5424 ( 1996 (Pubitemid 26404015)
44. Mestecky J. & Russell M. W. Specifi c antibody activityglycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol. Lett. 124 57-62 ( 2009
45. Russell M. W. Reinholdt J. & Kilian M. Anti-infl ammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgGmediated complement activation. Eur. J. Immunol. 19 2243-2249 ( 1989 (Pubitemid 20024748)
46. Griffi ss J. M. & Goroff D. K. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J. Immunol. 130 2882-2885 1983.
47. Vidarsson G. et al. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J. Immunol. 166 6250-6256 ( 2001 (Pubitemid 32440757)
48. Jarvis G. A. & Griffi ss J. M. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J. Immunol. 147 1962-1967 ( 1991
49. Waldo F. B. & Cochran A. M. Mixed IgA-IgG aggregates as a model of immune complexes in IgA nephropathy. J. Immunol. 142 3841-3846 ( 1989 (Pubitemid 19164412)
50. Jarvis G. A. & Griffi ss J. M. Human IgA1 initiates complement-mediated killing of Neisseria meningitidis. J. Immunol. 143 1703-1709 ( 1989 (Pubitemid 19217441)
51. Janoff E. N. et al. Killing of Streptococcus pneumoniae by capsular polysaccharide-specifi c polymeric IgAcomplementand phagocytes. J. Clin. Invest. 104 1139-1147 ( 1999 (Pubitemid 29536325)
52. Roos A. et al. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167 2861-2868 ( 2001 (Pubitemid 32768920)
53. Endo T. Mestecky J. Kulhavy R. & Kobata A. Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses. Mol. Immunol. 31 1415-1422 ( 1994 (Pubitemid 24381798)
54. Magnusson K. E. & Stjernström I. Mucosal barrier systems. Interplay between secretory IgA (SIgA)IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes. Immunology. 45 239-248 ( 1982 (Pubitemid 12214173)
55. Biesbrock A. R. Reddy M. S. & Levine M. J. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect. Immun. 59 3492-3497 ( 1991
56. Russell M. W. & Kilian M. Biological activities of IgA. In Mucosal Immunol. (MesteckyJ.BienenstockJ.LammM.E.MayerL.StroberW.McGheeJ.R.eds) 267-289 ( Elsevier/Academic PressAmsterdam 2005
57. Wines B. D. Willoughby N. Fraser J. D. & Hogarth P. M. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptorFCα RIis revealed by SSL7 binding at the Cα 2/Cα 3 interface of IgA. J. Biol. Chem. 281 1389-1393 ( 2006
58. Frithz E. Héden L. O. & Lindahl G. Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes. Mol. Microbiol. 3 1111-1119 ( 1989 (Pubitemid 19208297)
59. Stenberg L. O ' Toole P. W. Mestecky J. & Lindahl G. Molecular characterization of protein Sira streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J. Biol. Chem. 269 13458-13464 ( 1994 (Pubitemid 24206120)
60. Héden L. O. Frithz E. & Lindahl G. Molecular characterization of an IgA receptor from group B streptococci: sequence of the geneidentifi cation of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur. J. Immunol. 21 1481-1490 ( 1991
61. Pleass R. J. Areschoug T. Lindahl G. & Woof J. M. Streptococcal IgAbinding proteins bind in the Cα 2-Cα 3 interdomain region and inhibit binding of IgA to human CD89. J. Biol. Chem. 276 8197-8204 ( 2001
62. Lewis M. J. Meehan M. Owen P. & Woof J. M. A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system. J. Biol. Chem. 283 17615-17623 ( 2008
63. Lu L. Lamm M. E. Li H. Corthesy B. & Zhang J. R. The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. J. Biol. Chem. 278 48178-48187 ( 2003 (Pubitemid 37523271)
64. Elm C. et al. Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J. Biol. Chem. 279 6296-6304 ( 2004 (Pubitemid 38248762)
65. Senior B. W. Dunlop J. I. Batten M. R. Kilian M. & Woof J. M. Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases. Infect. Immun. 68 463-469 ( 2000 (Pubitemid 30056495)
66. Batten M. R. Senior B. W. Kilian M. & Woof J. M. Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases. Infect. Immun. 71 1462-1469 ( 2003 (Pubitemid 36254333)
67. Chintalacharuvu K. R. et al. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infect. Immun. 71 2563-2570 ( 2003 (Pubitemid 36519870)
68. Senior B. W. & Woof J. M. Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases. Infect. Immun. 73 1515-1522 ( 2005 (Pubitemid 40470737)
69. Senior B. W. & Woof J. M. The infl uences of hinge length and composition on the susceptibility of human IgA to cleavage by diverse bacterial IgA1 proteases. J. Immunol. 174 7792-7799 ( 2005 (Pubitemid 40806287)
70. Senior B. W. & Woof J. M. Sites in the CH3 domain of human IgA1 that infl uence sensitivity to bacterial IgA1 proteases. J. Immunol. 177 3913-3919 ( 2006 (Pubitemid 44359925)
71. Johnson T. A. Qiu J. Plaut A. G. & Holyoak T. Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of Haemophilus infl uenzae immunoglobulin A1 protease. J. Mol. Biol. 389 559-574 ( 2009
72. Boehm M. K. Woof J. M. Kerr M. A. & Perkins S. J. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J. Mol. Biol. 286 1421-1447 ( 1999 (Pubitemid 29121726)
73. Dechant M. & Valerius T. IgA antibodies for cancer therapy. Crit. Rev. Oncol. Hematol. 39 69-77 ( 2001
74. Corthésy B. Recombinant secretory immunoglobulin A in passive immunotherapy: linking immunology and biotechnology. Curr. Pharm. Biotechnol. 4 51-67 ( 2003 (Pubitemid 36312909)
75. Bakema J. E. & van Egmond M. Immunoglobulin A: a next generation of therapeutic antibodies? MAbs. 3 352-361 ( 2011
76. van der Pol W. Vidarsson G. Vile H. A. van de Winkel J. G. & Rodriguez M. E. Pneumococcal capsular polysaccharide-specifi c IgA triggers effi cient neutrophil effector functions via FCα RI (CD89). J. Infect. Dis. 182 1139-1145 ( 2000
77. Rodriguez M. E. et al. Fc receptor-mediated immunity against Bordetella pertussis. J. Immunol. 167 6545-6551 ( 2001 (Pubitemid 33081590)
78. Hellwig S. M. M. van Spriel A. B. Schellekens J. F. P. Mooi F. R. & van de Winkel J. G. J. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect. Immun. 69 4846-4850 ( 2001 (Pubitemid 32674464)
79. Balu S. et al. A novel human IgA monoclonal antibody protects against tuberculosis. J. Immunol. 186 3113-3119 ( 2011
80. Stockmeyer B. et al. Triggering FCα -receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 165 5954-5961 ( 2000
81. van Egmond M. et al. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of FCα RI (CD64) and FCα RI (CD89). Cancer Res. 61 4055-4060 ( 2001 (Pubitemid 32720970)
82. Dechant M. et al. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood. 100 4574-4580 ( 2002 (Pubitemid 35429700)
83. Otten M. A. et al. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J. Immunol. 174 5472-5480 ( 2005 (Pubitemid 40593187)
84. Lohse S. et al. Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing. J. Immunol. 186 3770-3778 ( 2011
85. Bakema J. E. et al. Targeting FCα RI on polymorphonuclear cells induces tumor cell killing through autophagy. J. Immunol. 187 726-732 ( 2011